13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 69 holding rows worth $1,654,958,467.
- Accession
- 0001172661-26-001209
- Filer
- CIK 1792126
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 69 entries on the cover page, a total value of $1,654,958,467 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,654,958,467 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,000,000 | $159,300,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 375,000 | $110,527,500 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,125,000 | $108,031,250 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $80,221,875 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,000,000 | $79,650,000 | dollars as filed | call |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 310,000 | $68,475,900 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 400,000 | $53,942,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 13,000,000 | $48,360,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 3,500,000 | $42,490,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 600,000 | $41,730,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 510,000 | $40,499,100 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 950,000 | $39,358,500 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 4,200,000 | $37,212,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 500,000 | $36,065,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 200,000 | $35,198,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,375,000 | $34,952,500 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 200,000 | $34,000,000 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 750,000 | $30,300,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 650,000 | $29,991,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 850,000 | $29,503,500 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,200,000 | $26,712,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,000,000 | $25,120,000 | dollars as filed | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,050,000 | $25,021,500 | dollars as filed | call |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,250,000 | $24,450,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,500,000 | $23,450,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,750,000 | $23,065,000 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 850,000 | $22,703,500 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 190,000 | $20,337,600 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,550,000 | $19,406,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 300,000 | $19,062,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 225,000 | $17,772,750 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 675,000 | $16,152,750 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 450,000 | $15,786,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 450,000 | $15,556,500 | dollars as filed | call |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 350,000 | $14,437,500 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 300,000 | $13,890,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,000,000 | $13,800,000 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 3,311,000 | $13,310,220 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,700,000 | $13,124,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 315,000 | $12,981,150 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 950,000 | $11,476,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 130,000 | $10,115,300 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 350,000 | $9,506,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 500,000 | $9,485,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 850,000 | $8,925,000 | dollars as filed | call |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 200,000 | $8,304,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 115,000 | $7,498,000 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 600,000 | $7,116,000 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,150,000 | $6,175,500 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 395,000 | $6,094,850 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 210,000 | $5,520,900 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 340,000 | $5,236,000 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 1,000,000 | $5,230,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 200,000 | $5,002,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 195,000 | $4,017,000 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 2,000,000 | $3,860,000 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 500,000 | $3,850,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 450,000 | $3,681,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 300,000 | $2,796,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 100,000 | $2,775,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 473,563 | $2,732,459 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,100,000 | $2,420,000 | dollars as filed | |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 140,000 | $2,153,200 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 600,000 | $1,806,000 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 100,000 | $1,308,000 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,850,000 | $770,895 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 23,548 | $656,518 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 25,000 | $479,250 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $22,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-001209 | this filing | 2026-02-17 | acceptance time not in the bulk data set |